Clarius Group LLC’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-838
Closed -$220K 444
2025
Q2
$220K Sell
838
-94
-10% -$22.9K 0.01% 431
2025
Q1
$217K Sell
932
-2
-0.2% -$485 0.01% 441
2024
Q4
$214K Buy
+934
New +$214K 0.01% 415
2024
Q2
Sell
-975
Closed -$213K 479
2024
Q1
$213K Sell
975
-15
-2% -$3.3K 0.01% 438
2023
Q4
$225K Sell
990
-70
-7% -$14.7K 0.02% 429
2023
Q3
$213K Sell
1,060
-224
-17% -$47.2K 0.02% 430
2023
Q2
$266K Sell
1,284
-43
-3% -$8.34K 0.02% 424
2023
Q1
$262K Buy
1,327
+47
+4% +$9.67K 0.02% 421
2022
Q4
$259K Buy
1,280
+72
+6% +$14.1K 0.02% 418
2022
Q3
$213K Buy
1,208
+82
+7% +$16.8K 0.02% 439
2022
Q2
$227K Buy
1,126
+131
+13% +$27.9K 0.02% 407
2022
Q1
$269K Hold
995
0.02% 391
2021
Q4
$269K Buy
995
+68
+7% +$16.8K 0.02% 391
2021
Q3
$224K Buy
927
+18
+2% +$4.54K 0.02% 385
2021
Q2
$215K Buy
+909
New +$207K 0.02% 385

Other funds holding LH

Clarius Group LLC's LH Position: Q3 2025 in Review

Clarius Group LLC sold out of Labcorp (LH) in Q3 2025, closing a stake of 838 shares — an estimated $220K sold.

Clarius Group LLC first reported a position in LH in Q2 2021 and held it in 15 quarters. The position peaked at $269K in Q1 2022. 1,009 funds tracked by Wall St. Rank hold LH as of Q3 2025.

  • Clarius Group LLC reported no remaining Labcorp position as of Q3 2025 after selling out during the quarter.
  • Clarius Group LLC sold 838 Labcorp shares in Q3 2025, an estimated $220K.
  • Clarius Group LLC first reported a position in Labcorp in Q2 2021 and held it in 15 quarters.
  • Clarius Group LLC's Labcorp position peaked at $269K in Q1 2022.
  • 1,009 funds tracked by Wall St. Rank held Labcorp as of Q3 2025.

Based on Clarius Group LLC's 13F filing for Q3 2025, filed 14 Oct 2025.